Cargando…
P095 LEVELS OF IGG TO SARS-COV-2 IN RECIPIENTS OF COVID-19 VACCINES: LONGITUDINAL MONITORING WITH QUANTITATIVE ASSAY
Autores principales: | Patel, J., Keshavarz, B., Richards, N., Workman, L., Muehling, L., Murphy, D., Eschenbacher, W., Nelson, M., Platts-Mills, T., Wilson, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566842/ http://dx.doi.org/10.1016/j.anai.2021.08.116 |
Ejemplares similares
-
Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection
por: Keshavarz, Behnam, et al.
Publicado: (2022) -
Quantitative Measurement of IgG to SARS-CoV-2 Proteins Using the Phadia ImmunoCAP 250
por: Keshavarz, Behnam, et al.
Publicado: (2021) -
Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine
por: Richards, Nathan E., et al.
Publicado: (2021) -
Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273
por: Ailsworth, Samuel M., et al.
Publicado: (2023) -
Prevalence of α-Gal IgE and Mammalian Meat Allergy in a COVID-19 Vaccine Employee Cohort
por: Richards, Nathan, et al.
Publicado: (2022)